Vaccinology: A sweet cleft in HIV's armour

14 December 2011


Nature 480,324–325(15 December 2011) doi:10.1038/480324a By Quentin Sattentau, James Martin Senior Fellow, Institute for Vaccine Design

View Journal Article / Working Paper

The structure of an antibody that potently neutralizes a wide range of HIV-1 strains, together with a minimal antigen mimic, is an advance towards the design of vaccines that may elicit protective responses.